NEW YORK (GenomeWeb News) – Rockland Immunochemicals said today that it will market LIMR Development's cellular assays for research purposes.

The alliance builds on an earlier agreement between Gilbertsville, Pa.-based Rpckland and LIMR, which is a business development subsidiary of the Lankenau Institute for Medical Research.

Under the new agreement, Rockland will sell LIMR's CellCountEZ, OxPhos, RadDose, and Intracellular ThiolEZ assays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.